Time Medical India - Reverse Merger Announcement

15 December 2023 -  Time Medical Holding is pleased to announce the successful reverse merger of its subsidiary company, Time Medical International Ventures (India), with Fischer Chemic Limited listed on the Bombay Stock Exchange (BSE), at a valuation north of US$100 mil.

The acquiring entity will be renamed to Time Medical Digital Health and Imaging Ventures Limited & start trading on BSE, one of the fastest growing stock exchanges.  At the time of the reverse merger, Time Medical Holding holds 51% shareholding, 25% shares was exchanged with Fischer Chemic Limited and remaining shares collectively invested/ funded by its Directors Mr Ravindran Govindan and Mr Shankar Varadharajan.

Time Medical Digital Health and Imaging Ventures Limited's manufacturing facility opened early this year in Andhra Pradesh MedTech Zone (AMTZ), Vishakhapatnam India to produce new generation Magnetic Resonance Imaging (MRI) system & provide a suite of innovative diagnostic imaging solutions to serve the fast growing India as well as global markets. The company will focus on offering comprehensive and dynamic diagnostics solutions including Health ATMs, HIS, EMR and Clinical Management systems using AI & Machine Learning to meet the current needs in the healthcare market.

“We are poised to enter the medical diagnostic imaging industry in this fast-growing and soon to be the largest market with a stronger foothold with this reverse merger, providing us the needed resources to fulfil an overwhelming strong order book in 2024. Our listed company will not just manufacture MRIs but also focus on expanding our healthcare software and solutions including for mental wellness, a multi-billion market. We have already made sales globally including the African and Middle East continent, and will continue to explore regions that are underserve with our innovative solutions at an affordable cost," said the Chairman & CEO of Time Medical Digital Health and Imaging Ventures Limited, Ravindran Govindan. 

Announcement of Appointment: Appointment of CEO Asia

Time Medical is pleased to appoint Mr Ravindran Govindan as CEO of Asia, effective immediately. 

Graduated with a law degree from University of Singapore, Ravi is the first angel investor of Time Medical and have since supported the company in fund raising and opening up international markets using his personal network in the region while holding the hat of a board member.

“We are elated to have Ravi’s agreement to take up an active role now to help the company expand globally.   His experience leading billion dollar companies before and his strong background in Medtech industry has been instrumental in helping the company in the last decade.  Having done more than a dozen IPOs and M&A in ASEAN and mentoring numerous Medtech companies particularly in India, we can certainly look to him to help the company build a strong organization of sales and marketing to catch the fast-growing opportunities in Asia medical imaging service, particularly in India and SE Asia." commented Professor Q. Y. Ma, Chairman and CEO of Time Medical.

Time Medical Participated in ISMRM Annual Meeting & Exhibition 2023

June 3rd – 8th 2023 - The International Society for Magnetic Resonance in Medicine (ISMRM) held its annual conference at the Metro Toronto Convention Center in Canada, the first on site MRI industry event after the pandemic, attracting over 6,000 radiologists, researchers, and manufacturer representatives from around the world.  More than 160 companies and medical institutes participated in the exhibition, including Time Medical (TM) and GE Healthcare, Philips and Siemens Healthineers (GPS).

The keynote Ernst Lecture (a Nobel Prize laureate in the MRI field) this year was delivered by Prof. Richard Ehman, the chief radiologist at Mayo Clinic and an advisor to Time Medical. Prof. Ehman is a world-renowned authority in the MRI field and former president of ISMRM. In his speech, he reviewed the development of MRI from science to medical, and pointed out while a new drug takes an average of 14 years from invention to product to clinical application, but innovation cycle in medical imaging is relatively shorter.  E.g. X-ray was used clinically in its second year of invention, and only four years for CT invention to be clinically-ready product. Today's MRI technology, such as parallel imaging is even shorter.  He also shared that the number of disruptive innovative inventions in the past 20 years has been decreasing, and called on the industry to promote disruptive innovation through industry-academia-research collaboration.

Prof. Richard Ehman, the chief radiologist at the Mayo Clinic Group gave a speech

Prof. Richard Ehman, the chief radiologist at the Mayo Clinic Group gave a speech

At the event, a special session on MRI in emerging countries saw experts from Singapore, India, South Africa and Chile introduced the development of MRI imaging service in Southeast Asia, India, Africa and Chile.  Prof. Khong Pek Lan, Dept. Head of Diagnostic Radiology at the National University Hospital in Singapore, presented a clinical survey report on MRI from numerous hospitals in Southeast Asia. The report pointed out that most parts of Southeast Asia such as Indonesia, Philippines, Vietnam and Myanmar lack MRI, radiologists and technologists.  The number of MRI systems per million people in Thailand, Vietnam, Philippines and Indonesia are only 3.1, 2.7, 1, and 0.4 respectively, significantly lower than 38 in United States and 16.8 in Singapore. Furthermore, the cost of MRI diagnosis in these countries is relatively high, ranging from 250 to 400 USD, making it inaccessible for majority.  As such, Prof Khong called on the local government to increase investment to improve the accessibility of medical diagnostic services.

The CEO of an India company gave a talk on the development of India MRI industry and shared that the total installed MRI in India is around 6000 currently and it is expected that there will be over 600 more MRIs to be installed in 2023, showing the huge market growth potential in India. However, the market needs more innovative and cost-effective MRI systems and service, such as mobile imaging.

Prof. Khong Pek Lan, head of the Department of Diagnostic Radiology at the National University Hospital in Singapore and TM Team

During the conference, TM sales team hosted dozens of radiologists and researchers from more than 20 countries across Europe, America and Asia. The company's neonatal MRI system aka NEONA, attracted widespread attention from pediatric radiology experts from institutions such as Harvard Medical School's Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH), Mayo Clinic, Lurie Children's Hospital of Chicago, Toronto Sick Children Hospital, National University Hospital in Singapore, and Memorial Sloan Kettering Cancer Center (MSKCC).  Time Medical also showcased its ultra-high-field 7T/9.4T biomed MRI system, NOVA, which attracted interest and inquiries from several universities in Europe and the US, including Prof. Bruce Rosen of Harvard Medical School's MGH, and Prof. Keith Thulborn, a sodium MRI expert from the University of Illinois at Chicago, who expressed their intention to cooperate.

Dr. Sunitha Thakur, Dr. Katja Pinker from MSKCC radiology dept and TM Team

Prof. Richard Ehmen and his team with TM Team

Harvard Medical School's MGH Prof. Bruce Rosen and his team with TM Team

Prof. Clare Tempany, director of the Radiology Interventional Surgery Center at Harvard Medical School’s BWH and this year's ISMRM gold medal winner with TM Team

On the evening of June 7th, the Oversees Chinese MRI Medical Association (OCMRM) held its 2023 annual meeting in Toronto, attended by more than 200 Chinese MRI experts from around the world. TM was invited to speak at the conference, Mr. Alec Leung, the company's Vice President and International Sales Director, introduced TM's innovative 3B products and high-temperature superconducting MRI technology.

Mr. Alec Leung, the company's Vice President and International Sales Director delivered a speech

Mr. Alec Leung, the company's Vice President and International Sales Director delivered a speech

Siemens Healthineers highlighted the clinical application of 7T whole-body MRI brain imaging at the conference.  Thus far Siemens has installed over 26000 MRI worldwide with over 100 are 7T whole body MRI.  Prof. Ma and TM team met with the new CEO of Siemens Healthineers MRI division and his team (VP of Strategic Development, VP of Marketing, etc.) to discuss in-depth cooperation on the development of innovative products such as ultra-high field MRI and ultra-low field MRI. The CEO of Siemens Healthineers MRI division previously overlook the operation of Siemens' MRI facility in Shenzhen, China, and is familiar with the China market. The two parties will arrange for the Siemens Healthineers team to visit Time Medical's Hong Kong base.

GE Healthcare launched their artificial intelligence deep learning technology, Sonic DL, at the conference which could reduce cardiac MR scan time by 80%. The CEO of GE Healthcare's MRI division visited TM’s booth to examine the neonatal MRI system. The CEO discussed with the TM team on potential partnership, including comprehensive market cooperation on TM’s neonatal MRI, permanent magnet MRI as well as GE's Sonic DL products.

Time Medical Team

Time Medical Invited to Speak in CIBR Annual Conference

15th May 2023 – Time Medical was invited to attend the 2023 Annual Conference of the Coalition for Imaging & Bioengineering Research (CIBR), held at Hall of the States in Washington, D.C.  Representatives from over ten government agencies and social NGO groups, including the National Institutes of Health (NIH), dozens of universities and hospitals, and more than ten medical tech companies were present.  There were three themed roundtable sessions held for “mobile cancer imaging service”, “artificial intelligence (AI) regulations” and “new medical device registration”.

Prof. Q.Y. Ma, CEO of Time Medical (TM) was invited to speak on “mobile cancer imaging service” and also co-chaired the session on mobile cancer diagnosis with Dr. Chris Eusemann, R&D vice president of Siemens Healthineers. Prof. Ma's speech focused on mobile medical community screening service and he also introduced the mobile digital radiography (DR) vehicle screening service launched by TM during the epidemic, to conduct lung examinations on returning students when school re-opened.  Aided with AI, each vehicle could screen & test 1,000 students per day, amongst which, more than 20 out of 5,000 students were diagnosed with tuberculosis and other diseases. Post-epidemic, TM continued to use mobile DR to perform lung screening in communities and remote areas. In Hainan for example, 25,000 residents were screened for lung diseases, and 0.5% of them were detected with lung cancer and tuberculosis. TM’s mobile DR+AI capability became an effective method for lung disease screening in the community.

Prof. Ma also spoke about TM cooperating with Harvard School of Public Health to launch breast cancer magnetic resonance (MR) screening community service projects, using mobile MR diagnosis services developed by TM as a fast and accurate dedicated breast MRI.  Statistic shows in 2022, over 280,000 women in the US were diagnosed with breast cancer, bringing the number of breast cancer patients in US to more than 4 million.  While there are 8,600 mammography centers in the US able to screen 80% (50 million) women over the age of 40 each year, but X-ray-based mammography has relatively low precision and risk of radiation.  More accurate and safer breast cancer screening diagnostic is MRI, but that is more expensive.  TM uses technological innovation and AI to greatly shorten the time taken for breast MRI screening (improving patient throughput), hence could reduce the price of screening down to mammography level of about $100-200 US dollars. Prof. Ma presented the opportunity to the conference communities to cooperate and jointly promote the mobile breast MR screening service to benefit more patients globally.

Prof. Ma's speech aroused interest and active discussions among the participants. Representatives of American Breast Cancer Imaging Society, UC San Diego Medical Center, Anderson Cancer Center, University of Michigan Medical Center, Medical Imaging Data Center, as well as other breast imaging experts expressed their support for this project and keen intention to collaborate.

Prof Ma spoke at the special session on mobile diagnosis of cancer

Prof. Judy Gichoya deliver her speech at the AI medical session

Dr. Qi Duan, Program Director of Health Informatics Division of National Institute of Biomedical Imaging and Bioengineering and Prof. Judy Gichoya, Emory University School of Medicine chaired the AI session.  Prof Gichoya, a strong promotor of AI in healthcare, indicated that the new AI tech such as ChatGPT will inevitably impact our society and healthcare.  Large scale Chat GPT will change the digital healthcare, particularly in medical education and community diagnosis service.

At this meeting, Michael Harsh (TM’s Senior Advisor), Julie Chow (TM’s MD for Global Imaging) and Prof Ma discussed potential collaborations with the representatives of National Institute of Biomedical Imaging and Bioengineering (NIBIB), Food and Drug Administration (FDA), National Institute of Standards and Technology (NIST), Advanced Research Projects Agency for Health (APRA-H), American College of Radiology, Society for Breast Imaging (SBI), Society for Interventional Radiology (SIR), American Academy of Physical Medicine (AAPM), Society for Nuclear Medicine and Molecular Imaging (SNMMI), Brain Aneurysm Foundation, Focused Ultrasound Foundation, Medical Imaging Data Center (MIDRC), and National Health Center Heart Lung and Blood Institute (NHLBI) and other institutions.

Alongside, the 2023 Medical Imaging Technology Showcase was held by CIBR at Rayburn House of Capitol Hill.  Twenty-nine young professors and doctors from first-class universities and hospitals demonstrated the latest research achievements in the fields of cancer imaging, AI, CT, MRI, PET and interventional radiology.  Prof Ma, Michael Harsh and Julie Chow from Time Medical participated in the tech show to discuss in-depth with the AI and breast MR researchers from Harvard Medical School, MSKCC, and UC San Francisco Medical Center. 

The event ended with the Chairman of Brain Aneurysm Foundation, Tom Tinlin sharing his personal story. Tom was a longtime commissioner of Boston Transportation Department and is an aneurysm patient himself. He declared in front of 200 participates in the Rayburn House that “innovative tech of imaging and intervention saved my life” and thanked all the people in the imaging profession for their contribution to the advancement of medical imaging and healthcare service.

Prof Ma, Michael Harsh and Renée L. Cruea (CIBR Executive Director)

PROF MA, TOM TINLIN (BRAIN ANEURYSM FOUNDATION, CHAIRMAN) and CHristine Buckley (Brain ANEurysm Foundation, Executive Director & Board President)

Tom Tinlin, longtime Boston Transit Commissioner gave keynote speech in the Med Tech Show

Time Medical Officially Opens New Hong Kong Production Facility at Tai Po MARS Centre

Time Medical (TM), a leading enterprise in the medical imaging field, today announced the official opening of its new Hong Kong production facility located at the MARS Centre at Tai Po INNOPARK, becoming the first large-scale medical equipment production facility in Hong Kong and the largest MRI production base in the Greater Bay Area and Southeast Asia. The production facility specialises in R&D and production of high value-add neonatal and breast screening superconductor magnetic resonance imaging (MRI) systems.

The new Time Medical production facility covers an area of 30,000 sq. ft. at the MARS Centre, equipped with advanced technologies, seamless logistics support and a tightly-integrated manufacturing environment. Hong Kong Science and Technology Parks Corporation (HKSTP) repositioned the three industrial estates in Tai Po, Yuen Long and Tseung Kwan O as INNOPARKS in 2021, to drive innovation and technology opportunities and long-term economic development in Hong Kong through Innofacturing. The new production facility will greatly facilitate the productivity of Time Medical's new-generation neonatal and breast screening MRI systems, plus advance the mission for New Industrialisation and high-value manufacturing proposed in Hong Kong’s Innovation & Technology Development Blueprint.

Professor Dong Sun, Secretary for Innovation, Technology and Industry, formally opened the new production facility and said in his speech, “Hong Kong has unique advantages in life sciences and strong capabilities in scientific research. The Budget released by the Financial Secretary last month also highlights our strength in R&D and fully supports the construction of the second Advanced Manufacturing Centre (AMC) operated by HKSTP. The Government is working in full swing to lay a solid foundation for New Industrialisation in Hong Kong, by promoting interactive development of upstream, midstream and downstream sectors. Time Medical provides a major boost to the city’s industrial development with its one-stop shop featuring R&D, design, production and sales of high value-added medical equipment in Hong Kong.”

Dr Q.Y. Ma, Founder and Chief Executive Officer of Time Medical, said: “We are grateful for the support from the Innovation, Technology and Industry Bureau and the HKSTP. After years of hard work, our team created the first MRI prototype for infants from within the R&D ecosystem at the Science Park and today's opening ceremony is a proof of our rapid growth in Hong Kong. The first batch of pediatric MRI systems made in Hong Kong will be used in top hospitals around the world. We are confident that these innovative pediatric products will soon emerge as premium ‘Hong Kong Brands’ and be exported to more regions such as Asia, Europe and the US.”

Dr Sunny Chai, Chairman of HKSTP, said in his speech: “HKSTP has been actively promoting the “R&D to Innofacturing" concept to develop a new generation of high-end manufacturing for Hong Kong, while enhancing the Hong Kong brand and creating more job opportunities for young people. I believe that in the future, there will be more successful I&T companies like Time Medical to shine on the stage in Hong Kong, the Greater Bay Area and even across the globe with their R&D achievement, realising numerous possibilities for Hong Kong Innofacturing.”

Time Medical is a leading innovator in the medical imaging industry. It is committed to bringing advanced, accessible and affordable medical imaging diagnostic services to the world, focused on developing dedicated MRI systems for Baby, Breast, and Brain (3B) diagnosis. With over 500 installations in hospitals and clinical centers across 16 countries, the company is already leading China's private hospital MRI market and has 40% share in China's pet MRI market. Time Medical’s R&D team originated from Columbia University, Harvard Medical School and University of Hong Kong, and has already acquired a number of patented technologies in the field of medical imaging; Currently, it has established R&D, sales and operation centers in Hong Kong, Shanghai, Silicon Valley and Singapore.  

Time Medical will leverage its new production facility in Hong Kong to produce the dedicated superconductor MRI system designed optimally for neonates - Neona. Its neonatal magnetic resonance imaging (MRI) system is a patented product of Time Medical using original revolutionary technology, and it has officially obtained the US Food and Drug Administration (FDA) approval and won the Geneva International Invention Award. Neona is lightweight, compact in size, safe and reliable. It is suitable for adoption by around 8,000 different neonatal intensive care units (NICUs) globally, providing dedicated and radiation-free diagnosis for infants. Neona is developed by the engineering team of Time Medical based at Hong Kong Science Park, making it the first high-end medical device that is "Innovated, Designed and Made in Hong Kong" and it will be exported to the US, Europe and mainland China, propelling the Hong Kong brand in the international medical market.

MARS Centre at the Tai Po INNOPARK was launched in 2021, it is a modern industrial space purpose-built to fit the high-end manufacturing requirements, dedicated to the manufacturing of personal protection equipment (“PPE”) and relevant materials, medical devices and related equipment as well as precision instruments. Time Medical is one of the first batch of enterprises settled down, its new Hong Kong production facility is designed to have an annual production capacity of 200 units, with an annual output value of HK$1.5 billion. Time Medical looks forward to establishing its facility as Asia's leading digital medical imaging R&D centre and permanent manufacturing base, as well as to contribute to the development of the I&T ecosystem and healthcare industry in Hong Kong and the Greater Bay Area.

Professor Dong Sun, Secretary for Innovation, Technology and Industry (third from left), Dr Q.Y. Ma, founder and Chief Executive Officer of Time Medical (third from right), Mr Ravi Govin, Director and Chief Executive Officer of Asia, Time Medical (second from right), Mr Edward Yeung, director of Time Medical (first from right), Dr Sunny Chai, Chairman of HKSTP (second from left) and Mr Albert Wong, Chief Executive Officer of HKSTP (first from left), cut the ribbon for Time Medical's new Hong Kong production facility in MARS Centre.

Professor Dong Sun, Secretary for Innovation, Technology and Industry, shared that the Government is working in full swing to lay a solid foundation for New Industrialisation in Hong Kong by promoting interactive development of the upstream, midstream and downstream sectors. He added that Time Medical provides a major boost to the city’s industrial development with its one-stop shop featuring R&D, design, production and sales of high value-added medical equipment in Hong Kong.

Dr Q.Y. Ma, Founder and Chief Executive Officer of Time Medical, said today's opening ceremony is a proof of the company’s rapid growth in Hong Kong and confidence that the innovative pediatric products manufactured in Hong Kong will soon emerge as premium ‘Hong Kong Brands’ and be exported to more regions such as Asia, Europe and the US.                                              

Professor Sun was accompanied by Dr Ma to visit Time Medical’s new production facility in MARS Centre at Tai Po INNOPARK and learn more about the achievement of “R&D to Innofacturing” and MRI solutions “designed and made in Hong Kong”.

US FDA Approval Officially Awarded to the First-of-its-kind Neonatal MRI Developed by Time Medical

February 21st 2023 - Time Medical (“TM”) officially obtained the US FDA approval for its neonatal magnetic resonance imaging (MRI) system (a.k.a NEONA) on this day.

A world-first superconducting MRI system dedicated for baby diagnosis, NEONA can significantly improve the precision and image quality of fragile newborns, infants and children. This innovation is designed and developed by the Company’s product development team in Hong Kong, to be lightweight and compact to fit inside a Neonatal Intensive Care Unit (NICU), greatly reducing the health risk of having to move young patients around.

NEONA is also faster and safer relative to a typical adult MR as the system has high efficiency transmission RF specially designed to enable high quality imaging while maintaining low RF power that reduces scanning risk overall.

With US FDA awarded, the Company can officially start its marketing and production to reach an unmet need for specialized neonatal MRI from 8,000 NICUs globally. With this, the Company can also progress it’s discussion with the leading companies in MR industry on global product distribution.

NEONA - an innovative system that has already won numerous international awards including the Geneva International Invention Award, is officially ready for the market!

PICA installation at the Studio Radiologico Federico in Cosenza, Italy

More good news from Time Medical. The PICA installation at the Studio Radiologico Federico in Cosenza, Italy has been completed as well! Customer is happy and satisfied with the image quality from our PICA MRI System. Time Medical is going to install more and more MRI Systems in Italy in the coming months!

#timemedicalsystems #PICAopenMRI #cosenza #openMRI #studioradiologicofederico

First PANION Pro Veterinary MRI in Italy

Time Medical is excited to announce the completion of installation of first PANION Pro Veterinary MRI in Italy. Thanks for Dr. Laporta Luca of Croce Azzurra Veterinaria to believe PHS and Time Medical and install the FIRST Veterinary MRI from Time Medical in Europe and it is the first Veterinary MRI in the Province of Taranto.

The dedicated veterinary MRI from Time Medical comes with dedicated RF coils for animal scanning and the animal scanning software with optimized protocols!

#veterinarymri #veterinarymedicine #veterinaryradiology #veterinaryneurology #veterinarysurgery #timemedicalsystems

Time Medical Participated in the 41st J.P. Morgan Healthcare Conference

On January 9th, The 41st J.P. Morgan (JPM) Healthcare Conference 2023 kicked off its four-day run in San Francisco. This is the largest investment summit in the global healthcare industry, and notably the first in person conference in three years since the Covid-19 outbreak. The conference welcomed roughly 8,000 professionals, representing more than 550 leading biopharmaceutical, medical device and healthcare service companies, as well as medical investment institutions around the world. Time Medical (TM) was invited to participate in the conference, and company representatives included Professor Q.Y. Ma (CEO), Dr. Eric Gao (CTO), Gene Saragnese (Senior Adviser), Dr. Yuri Wedmid (SVP), and Julie Chow (MD).

TM representatives: Julie Chow, Gene Saragnese, Dr. Yuri Wedmid, Prof. QY Ma, Dr. Eric Gao

The first keynote speaker at the conference was Jamie Dimon, CEO of JPM. He talked about the current economy in the United States, the outlook of the healthcare industry, and the challenges faced by medical and healthcare companies. He mentioned that a magnetic resonance imaging (MRI) scan in the US can range from $1,000 to $8,000. During the Q&A session, in response to this speech, Professor Ma said that through innovative technology and artificial intelligence (AI), future MRI scans can be reduced to only the price of ten cups of coffee. It will greatly reduce healthcare costs and enhance medical coverage. Jamie replied: “Digital Technology and AI will be the future for healthcare.”

JPM CEO Jamie Dimon’s speech

At the opening of the keynote session, JPM’s Global Head of Healthcare, Michael Gaito, mentioned that the financing environment for medical industry companies in 2022 was quite challenging, and investors paid special attention to balance sheets and business models. Looking ahead to 2023, he expects margin scale and balance sheet to continue to be very important themes, and sees innovation driving the healthcare industry. During the keynote session, Professor Ma, Gene met with Michael. Professor Ma introduced Time Medical as a company spun off from Columbia University and an innovative leader in medical imaging, and JPM Healthcare Asia team will be the lead sponsor for its listing in Hong Kong Stock Exchange. Michael congratulated Professor Ma and wished TM a successful IPO in the future.

On January 10th, the second day of the conference focused on medical technology, in which the CEOs of GE Healthcare, Siemens Healthineers, and Fujifilm Healthcare gave speeches.

GE Healthcare CEO Peter Arduini said: "Although inflation is serious, customers' demand for medical devices is growing strongly. We are seeing the supply chain environment continue to improve, and the industry outlook is optimistic. Looking forward, technological innovation and AI will be the key to the development of the medical imaging industry.” Peter pointed out that there are three strategies for the company’s development: i) to increase R&D investment, especially differentiated products and digital and AI technologies. GE Healthcare’s R&D investment from 2019 to 2021 has reached US$2.5 billion; ii) mergers and acquisitions (M&A), 4 companies have been acquired since 2020; and iii) strategic investment cooperation. Since 2020, 20 companies have completed equity investment and strategic cooperation. Peter further emphasized that M&A and strategic investment and cooperation are the main drives for the company's future growth.

Afterwards, Professor Ma, Gene and Peter had an in-depth discussion. GE Healthcare listed on Nasdaq on Jan 4th with its shares rising 8% on the same day. Professor Ma congratulated Peter on the success of the listing, and briefed the potential cooperation between TM and GE Healthcare MRI Division.

During the conference, Siemens Healthineers CEO, Bernd Montag, mentioned the company has unique resilience, which is mainly due to the foundation of globalization. Siemens Healthineers will expand existing markets through M&A and explore new markets in emerging countries/regions.

In the Q&A session, Bernd said that the 2020 pandemic did have an impact on the economy, but the medical industry has strong resilience. He indicated: “Economic recession is mainly an issue in the US. We see that many EU countries, China, India and other emerging markets are still growing." Professor Ma asked a question regarding this issue: "Medical and healthcare expenditures in many Asian countries have increased significantly in the past two years, for example India has more than doubled. How much will the revenue of Siemens Healthineers grow in Asia?" Bernd answered that the growth rate in Asia is 6-8%, and pointed out that with the lifting of China's pandemic restrictions this year, China's business growth rate will be higher.

Bernd, Gene, Yuri, and Professor Ma are old friends, and finally met up after three years of the pandemic.  Professor Ma and Bernd also discussed the potential strategic cooperation.

Keynote session at the conference

At the Jan 10th  keynote session, Professor Ma communicated with Dr. Renee Wegrzyn, director of APRA-H (second from left in the picture), and Dr. Robert M. Califf, Director of FDA (third from left in the picture), on the ultra-high-field brain science MR project.

On January 11th, Professor Ma and Amy Raimundo, Managing Director of the Kaiser Permanente Ventures in the US, discussed the breast MR mobile screening service project.

During the conference, the Time Medical team was also invited to participate in several events including the JPM Asia-Pacific reception, the dinner reception jointly organized by the Hong Kong Economic Development in San Francisco and Hong Kong Science Park, and China Night Event organized by M7 Global Biomedical Innovation Alliance.

Time Medical has significantly increased its visibility during this JP Morgan Healthcare Conference. The company not only had in-depth exchanges with the CEOs of global leading medical device companies, it also met with investment institutions from around the globe, which broadened the company's connections to the capital market in preparations for its public listing.

Time Medical Exhibited at the 108th RSNA and Held a Launching Ceremony on Neonatal MRI

Nov 27th - Dec 1st : The Radiological Society of North America’s 108th Scientific Assembly and Annual Meeting (RSNA) is an annual event held in Chicago. It is the largest and most influential international radiology industry conference and exhibition with more than 650 companies participating.  Time Medical (TM) is proud to exhibit in the largest booth in its history, showcasing the company’s innovative Neonatal MRI and Breast MRI.

Time Medical’s booth at the 108th RSNA

The highlight of RSNA this year was AI and breast cancer screening.  There were numerous special reports on AI from about a hundred companies participated in this field.  Prof. Elizabeth Morris, Chair of the Department of Radiology at the University of California, Davis (UCD) and a recognized expert in breast imaging, delivered the first keynote report of the conference on "Saving More Lives". She pointed out that while breast MR is an effective method for the diagnosis of dense breast, only 2% of women in the United States undergo breast MR screening and most of them do not have regular checkups.  Prof. Morris shared her personal experience that although she do mammography and ultrasound breast cancer screening test regularly, during her health checkup early this year, she received a breast cancer diagnosis that were not detected earlier.  Her 4mm invasive lobular tumor was found only after tissue had been removed from her breast during surgery.  As such, Prof. Morris strongly request for radiologists to advocate breast cancer screenings by MRI to save more lives.  "If we can screen for all kinds of cancers early and treat them with minor surgery at an early stage, cancer will become a common disease rather than a fatal one." said Prof. Morris.

During the exhibition, TM sales team hosted more than 100 distributors and potential clients from more than 16 countries including the United States, the United Kingdom, Germany, Portugal, Sweden, Canada, Australia, Argentina, Chile, Peru, Mexico, India, Saudi Arabia, Egypt, Thailand, and South Korea. The team connected with more than a dozen American hospitals and imaging diagnosis chain companies, whom showed strong interest in TM’s breast MRI as an essential modality for early and accurate screening of breast cancer. On the other hand, TM’s neonatal MRI also attracted much attention from various hospitals’ representatives, including Massachusetts General Hospital of Harvard Medical School, Three of top 10 US Children Hospitals (Cincinnati Children Hospital, Stanford Children's Hospital, Colorado Children's Hospital), as well as Cambridge University School of Medicine in the UK, Children Memorial Health in Poland and Children's Health Ireland.

TM executives also met several industrial executives during RSNA, including the CEO of Cannon Medical, the CEO of Siemens MRI Division, the GM of Philips MRI Division, the CEO of Mardamed, the chairman of UAE BPG and the CEO of Cura India etc. to discuss collaboration plans. Mr. Toshio Takiguchi, CEO of Canon Medical Systems visited TM booth to view the Neonatal MRI, and had a meeting with Prof. Ma for potential collaboration in Asia market. Cannon is No. 1 player in Asia medical imaging market and No. 4 globally.

Canon Medical CEO Toshio Takiguchi and Prof. Ma

Time Medical officially launched its neonatal MRI (a.k.a. NEONA) on Nov 29, 2022.  NEONA is the world's first superconducting MRI dedicated to infants, which greatly improves the quality of the diagnosis of newborns. This system was honored with the "Geneva Prize" at the Geneva Invention Congress. TM’s NEONA is light, fast, accurate and safe for it to be installed in the Neonatal Intensive Care Unit (NICU) for precise and radiation-free diagnosis of infants.  Currently there are more than 4,000 NICUs across Europe & US as well as more than 3,000 children's hospitals in Asia.

The NEONA launch ceremony started with Prof. Ma giving the product introduction and summarizing its features into the tagline: "Small and light, fast and safe".  The innovation of NEONA started with the suggestion from 2 top MRI experts - Professor Bradley and Mr. Michael Harsh.  After years of research and development, the prototype of NEONA was completed in 2019.  Affected by the COVID pandemic, the FDA application was delayed until July 2022. Today Time Medical's favorite “child” - NEONA, is finally born!

TM advisor and former GE Healthcare CTO Michael Harsh congratulated the birth of NEONA!  He said: "Today, the industry finally realized the importance of specialized MR, which will open up new markets. I am very happy that TM has made the specialized MR a reality!" Everyone celebrated with ribbon cutting and champagne popping.

The VIP guests who participated in the event included the chair of the Department of Radiology at Mayo Clinic  (the largest hospital group in the US) and former chairman of RSNA, Professor Richard Ehman; former CEO of GE Healthcare MRI Division Mr. Richard Hausmann; Professor Michael Gee, deputy director of the Department of Radiology at Massachusetts General Hospital of Harvard Medical School; Professor Wang Yi, a radiology expert from Cornell University School of Medicine; Mr. Anil Jain, GM of Refex Group in India; Mr. Bala, CEO of Cura India; and distributors from Europe and the US, etc.

Mr. Michael Harsh delivered a speech at the NEONA launching ceremony

Dr. Yuri Wedmid, Prof. Ma, Prof. Ehman, Mr. Richard Hausmann and Mr. Michael Harsh cutting ribbon

Prof. Garry Gold, head of the Department of Radiology at Stanford Medical School congratulated the team on the launch of NEONA

Yuri Wedmid, Michael Harsh, Michael Gee, Q.Y. Ma, Richard Hausmann and Richard Ehman

Prof. Brian Coley, Radiologist-in-Chief of Cincinnati Children’s Hospital congratulated TM

Yuri Wedmid, Anil Jain, Michael Harsh, Bala and Q. Y. Ma

CIBR (Coalition for Imaging and Bioengineering Research) held a meeting of the Steering Committee where Prof. Ma and Yuri were invited to attend.  Dr. Renee Wegrzyn, the inaugural Director of ARPA-H (Advanced Research Projects Agency for Health), a newly established interdepartmental funding agency in the US were invited to introduce the functions and goals of APRA-H.  She pointed out that the agency is different from the National Institutes of Health (NIH) and will mainly focus on high-risk, cutting-edge research and development projects in life and healthcare space such as how to prevent people from becoming patient. The agency will start operation early next year and expects active participation from CIBR members.  CIBR is an NGO in Washington DC and its members include more than 50 radiology departments of universities and 9 companies. Prof. Ma is one of the steering committee members of 9 companies (including GPS).

AuntMinnie, the largest professional website in the imaging industry, interviewed Yuri on TM’s innovative neonatal MRI product

Clients at TM booth

Time Medical Team

Time Medical Participated in the European Congress of Radiology for the First Time and Received Bulk Orders

From July 13th to 17th, the European Congress of Radiology (ECR) was held in Vienna, which is the second largest medical radiological event in the world after the Radiological Society of North America Annual Meeting (RSNA). The conference was canceled in the past two years due to the COVID 19 pandemic and resumed this year. More than 230 medical device companies participated in the exhibition of the Congress, including industry leaders such as GE Healthcare, Siemens Healthineers, and Philips.

This year is the first year of Time Medical's entry into the European market. Time Medical participated in the ECR for the first time and exhibited the company's flagship products NEONA and PICA. During the conference, the International Marketing Team hosted customers and distributors from more than 20 countries, including Italy, Portugal, Ukraine, Turkey, Bulgaria, Estonia, Israel, Romania, the United Arab Emirates and Egypt.

Time Medical made major achievement at the exhibition and signed bulk purchase MOUs with distributors in Italy, Portugal and other countries to distribute more than 100 permanent magnet MRI products in Europe in the next three years.

Time Medical and Italian distributor signed a MOU for bulk purchasing orders

Time Medical Participated at HKSTP 20th Anniversary Exhibition “INNOMART”

The Hong Kong Science and Technology Park Corporation (HKSTP) celebrates the 20th anniversary of its establishment. With the theme of “Innofacturing Tomorrow”, HKSTP organized a 5-day exhibition “INNOMART” to showcase the “Innovated, Designed and Made in Hong Kong” creations of 5 local technology enterprises. As one of the first innovation and technology enterprises at HKSTP, Time Medical is honored to participate the exhibition and showcase the world’s first neonatal magnetic resonance imaging (MRI).

During the event, founders of Time Medical including Professor Ma, Mr. Simon Yeung and Mr. Johnson Chong presented the company to Hong Kong Chief Executive Mr. John Lee and Innovation, Technology and lndustry Bureau (ITIB) officials. Professor Ma explained to CE that Time Medical (TM) team has been working on the medical imaging technology research and product development at HKSTP since 2008. The founding team originated from the Jockey Club Magnetic Resonance Engineering Center of the University of Hong Kong, who started their own business after graduating from HKU. Professor Ma reported to CE that TM is an authentic local brand of “Innovated, Designed and Made in Hong Kong” and expanded globally. After ten years of persistence, TM finally launched innovative products with hard-core technology, high profit margin and huge market potential.

The co-founders of Time Medical, Mr. Simon Yeung and Mr. Johnson Chong introduced the company's exhibit to the honorable guests, the world's first superconducting neonatal MRI NEONA - TM patented product with original technology that can greatly improve diagnosis precision and quality. Its compact and lightweight system that is specifically designed for easy installation in Neonatal Intensive Care Unit (NICU). NEONA has won the Geneva International Invention Award and has become the most popular product at the China International Import Expo. The system was designed and developed by the TM Hong Kong product development team at HKSTP. NEONA is the first high-end medical imaging system that is “Innovated, Designed and Made in Hong Kong”. There are currently 4,000 NICU in Europe and the United States; more than 3,000 maternity and childcare hospitals in China; and more than 3,000 children's hospitals or maternity hospitals in Asia. There is a huge market potential for neonatal MRI that can reach HK$100 billion. Time Medical will cooperate with leading companies in the industry to distribute its products globally and promote as a Hong Kong local brand in the international market.

HKSTP CEO Mr. Albert Wong further added that Time Medical is a local high-end manufacturing company in Hong Kong. During the event, ITIB Secretary Mr. Dong Sun, HKSTP Chairman Mr. Sunny Chai and other guests also visited TM’s exhibit.

Hong Kong's innovation and technology development is vigorous, and the global high-end medical equipment market is booming. Time Medical will seize the opportunity and make resolute efforts to become a world-class high-end medical equipment enterprise. With its disruptive technology and product advantages, TM will bring 3A (Advanced, Accessible, Affordable) medical diagnostic services to the global public and contribute to the development of Hong Kong's innovation and technology.

Prof. Ma presented TM’s innovative product to HK Chief Executive Mr. John Li

Prof. Ma introduced TM’s neonatal MRI to ITIB Secretary Mr. Dong Sun and HKSTP Former Chairperson Ms. Fanny Law Fan Chiu-fun

TM founders presented its innovative product to HK Chief Executive, ITIB Secretary and other officials

TM founders presented its innovative product to HK Chief Executive, ITIB Secretary and other officials

Photo of TM founders and HKSTP Former Chairperson Ms. Fanny Law Fan Chiu-fun

Time Medical Participated in the World's Largest Conference on Magnetic Resonance in Medicine

The 2022 International Society for Magnetic Resonance in Medicine (ISMRM) Conference was held in London on May 7th - 12th. Affected by the epidemic, the 2020 and 2021 conferences were cancelled. This year's conference is the largest event in the magnetic resonance (MR) medical industry in three years, with more than 4,000 people attending.

ISMRM 2022

Nearly 100 companies and professional organizations participated in the conference, including leading companies GE Healthcare, Philips Healthcare and Siemens Healthineers (GPS). Due to epidemic prevention and control, all local Chinese MRI companies including Neusoft and United Imaging were absent from this year's exhibition. Time Medical (TM) showcased the NEONA - World's First Superconducting Neonatal MRI and ultra-high field 7-9.4T NOVA Preclinical MR System at the exhibition, which attracted the attention of all parties in the industry. The event is a great promotion for TM and it will speed up the expansion of TM in the global market, particularly the European Market.

The Exhibition Booth of TM

At the exhibition, Time Medical hosted MRI specialists and radiologists from leading university medical schools and hospitals in the United States, the United Kingdom and Germany, including Harvard Medical School, Brigham and Women's Hospital, Harvard Children's Hospital, Stanford Medical School, Johns Hopkins University School of Medicine, University of Pennsylvania Children's Hospital, University of California San Diego School of Medicine, University of California Riverside, University of Illinois at Chicago, Cambridge University Hospital, University Hospital London, London Children's Hospital, Friedrich-Alexander University, etc. They expressed strong interest in TM’s neonatal MRI and ultra-high-field preclinical MRI.

Prof. Ma, Dr. Gao with Prof. Martin Graves of Cambridge University Hospital

Left: Prof. Ma, Prof. David Atkinson from University College London and Prof. Graeme Bydder, a leading MR expert

Right: Prof. Ma and a top MR expert Prof. Hu Xiaoping, Chair of the Bioengineering Department at the University of California, Riverside

International Marketing Director Alec and his team hosted more than a dozen distributors from all around the world at the exhibition, including distributors from the UK, Turkey, Romania, the US, Singapore, Sweden, Canada, Australia, and Austria. The existing French and Italian distributors of Time Medical made special trips to the exhibition. They all praised TM’s unique products and indicated that there will be more orders in the near future.

During the conference, the senior management of Time Medical (Prof. Ma, Dr. Gao, Alec) held meetings with the executive team of GE Global MR Division as well as Siemens MRI Division to discuss the potential cooperation.

Left: TM sales team and French distributor;  Right: Prof. Ma and Italian distributor

On the evening of May 11, the Overseas Chinese Society for Magnetic Resonance in Medicine (OCSMRM) held its 2022 annual meeting in London. More than 200 Overseas Chinese magnetic resonance experts from around the world participated. Prof. Ma from TM and the CEO of GE Global MRI were invited to speak at the meeting. Prof. Ma introduced Time Medical's innovative 3B products and high-temperature superconducting MR technology. The current and future presidents of the OCMRM Association, Prof. Lu Hanzhang and Prof. Wang Hao from Johns Hopkins University School of Medicine exchanged the research and development progress in brain imaging with Prof. Ma and Dr. Gao.

Professor Ma delivered a speech at the 2022 Annual Conference of the Overseas Chinese Society for Magnetic Resonance in Medicine

CEO of Time Medical gives an invited talk on medical imaging innovation at the Silicon Valley Global Innovation and Future Technology Summit (GIFTs)

On December 14th, the Fifth Global Innovation and Future Technology Summit is held at the Santa Clara Convention Center in Silicon Valley. The theme of this year summit is: Future Technology and Medical Outlook. The conference attracted about 500 people online and offline. Industrial leaders, VC fund partners, entrepreneurs and other professional elites from Silicon Valley, Boston, Germany, Israel, India, South Africa, etc. were invited to present in the conference. Including Two Turing Award winners, professors from top universities such as Stanford University, Harvard Medical School, and UC Berkeley, as well as the founder of Global Health Impact Fund. The topic of the conference is focused on the development of health industry in the post-epidemic era, including artificial intelligence medicine, future medical technology, and healthcare investment trends.

 Keynote speakers of the Summit include Professor Rosenblatt, the former executive VP and chief medical officer of Merck, he is also the director of the Harvard-MIT Medical Science and Technology Division; Dr. Uzzaman, founder of Pegasus Tech Venture; and  Professor Fitzgerald, professor of Stanford University School of Medicine and founder of Triventures Fund.

 In his speech, Professor Rosenblatt repeatedly emphasized "Don't kill the idea too early", as the innovative ideas of the biomedical industry are difficult to be accepted by the peers at first.

Dr. Uzzanan has invested in more than 200 global startup companies including SpaceX, Airbnb, 23andMe, Doordash, and Gojek. He pointed out three major technology trends in 2022: 1) Metaverse, more than 90 companies in the US have invested in it; 2) NFT (Non-Fungible Token), NFT sales in the third quarter of this year increased by 8 times, reaching USD10.7 billion; 3 ) Robots are widely used in manufacturing, logistics, and agriculture.

Professor Fitzgerald is a serial entrepreneur and has co-foundered 24 medical device companies in San Francisco Bay Area, 18 of which have been listed or acquired. He emphasized that the future medical and health trends are AI and Big Data, and leading American technology companies such as FAAG (Facebook, Apple, Amazon, and Google) are actively participating.

At the invitation of the conference organizer Silicon Valley Zhongguancun Venture Capital (ZGC), Professor Q. Y. Ma, Chairman and CEO of Time Medical, gave a speech on "Innovation and Future of Medical Imaging" at the Summit.

In his speech, Professor Ma focused on “Imaging in Community” of the post-epidemic era. During the epidemic, online healthcare consultations in the US have increased by 38 times, while routine hospital visits have dropped by 80%. Mobile medical diagnosis has become a new trend, which requires the use of artificial intelligence reading and tele-imaging diagnosis data platform technology. Time Medical is partnering with Harvard School of Public Health and others to initiate a global medical diagnosis service project. The goal is to provide advanced, affordable, and accessible (3A) digital diagnostic services to the community worldwide.

In terms of imaging system innovation, Professor Ma introduced the industry's latest development of miniaturized and specialized diagnostic imaging systems. Including innovative products such as mobile MR for operating rooms, pediatric MR for neonatal intensive care units, and breast MR for breast cancer screening in communities. Finally, Professor Ma introduced the technological breakthroughs in neuroimaging: the next generation of ultra-high field (9.4T～14T) MR with the goal to observe a single neuron alive, and to explore the mechanism and treatment of stroke and Alzheimer. In his conclusion remark, Professor Ma pointed out that the integration of artificial intelligence (AI), augmented reality (AR) with real image data will be the Future of Medical Imaging!

During the summit, Professor Ma also accepted a special interview with the Silicon Valley media. Time Medical executives Johnson Chong and Alec Leung also attended the event.

Group photo of Time Medical Team and Dr. Ella Li, partner of Silicon Valley ZGC Venture

Professor Fitzgerald (Left) and Professor Ma (Right)

Professor Ma (Left) and Dr. Goldman (Middle), the founder of Global Health Cooperation Fund

Time Medical at RSNA 2021

Time Medical participated in the 107th North American Radiology Annual Conference RSNA, the world's largest and oldest exhibition in the medical imaging industry. Affected by the global pandemic, the exhibition in 2020 was cancelled. There are 20,000 radiologists and more than 500 companies participated in 2021 RSNA. Time Medical, along with industrial leaders such as GE, Siemens, Philips, and others have participated in the exhibition. Time Medical's booth was placed next to GE Healthcare, which exhibited three innovative products of neonatal MRI, breast MRI and 1.5T whole body superconducting MRI.

During the RSNA exhibition, Time Medical team hosted numerous customers and distributors from all over the world including the United States, the United Kingdom, Germany, Sweden, Ukraine, Canada, South Korea, India, Egypt, Jordan, Turkey, Israel, Mexico, Argentina, Colombia, Peru, Ecuador and other countries. Many examined Time Medical’s innovative products and expressed their interests for distribution. Time Medical team has made sales leads of over 20 MRI systems throughout the exhibition (RSNA regulations do not allow customers and vendors to sign purchase agreements or MOU during the exhibition).

Time Medical has initiated several clinical research collaborations with leading medical schools in the United States. During the exhibition, radiologists from Harvard Medical School, Stanford Medical School, Memorial Sloan Kettering Cancer Center (MSKCC) in New York, Columbia University, Cornell University School of Medicine, University of California Medical Centers, etc. visited Time Medical’s booth to discuss potential collaboration projects such as the 7-14T ultra-high field MR, sodium MRI imaging, neonatal MRI, breast MR screening and other clinical scientific research and diagnostic applications.

Dr. Comstock, a leading breast imaging expert of MSKCC, discussed potential cooperation with Time Medical team in breast cancer MRI screening. Dr. Comstock is the promoter of rapid MRI breast cancer screening in the United States.

Professor Boada from Stanford Medical School discussed cooperation with Time Medical team in the diagnosis of cancer cells with MR sodium imaging. Professor Boada is a well-known expert in sodium imaging of brain tumour.

Time Medical advisor and former CTO of GE Healthcare, Michael Harsh came to the Time Medical’s booth to oversee innovative products. He highly praised the company's high-temperature superconducting (HTS) magnets and radio frequency (RF) technology, as well as its unique products such as neonatal MRI. Professor Hennig, a leading expert in medical imaging of European, also came to Time Medical’s booth to view the innovative products. Professor Kateb, Chairman of the International Association for Brain Imaging and Prevention and the Brain Imaging Foundation, visited Time Medical’s booth.

Former GE Healthcare CTO, Michael Harsh came to Time Medical’s booth

Professor Hennig visited Time Medical’s booth

Professor Kateb (second right), Chairman of the International Association for Brain Imaging and Prevention

Professor Jalali (right) from the University of California Los Angles, visited Time Medical’s booth

Senior management team of the American company, MardaMed visited Time Medical’s booth and discussed potential cooperation

The CEO of the Indian Medical Equipment Park AMTZ visit Time Medical’s exhibition

The senior management team of an Argentine distributor, GEMED examined Time Medical’s products. GEMED has arranged several customers from Latin America to view Time Medical’s products and has led to 5 MRI orders

During the exhibition, Time Medical’s management team held face-to-face meetings with the global MRI executives of GE, Siemens, and Philips. They discussed the collaborations in the global distribution of Time Medical’s neonatal MR, HTS magnets, and the development of next-generation ultra-high field MR, as well as cooperation in the Asian market. The executives of the three major companies all visited Time Medical's booth to examine the first superconducting neonatal MR and other innovative products.

On December 1, Professor Ma and Dr. Yuri Wedmid were invited to participate in the CIBR committee meeting. The meeting was attended by the committee members from 8 companies including GE, Siemens, Philips, Canon and Time Medical, as well as leading radiologists of more than 20 top hospitals and institutes, including National Institutes of Health (NIH) Institute of Biomedical Imaging and Bioengineering, MSKCC, Harvard Medical School, Anderson Cancer Center, Stanford School of Medicine, University of California Medical Centers, Cornell School of Medicine, and University of Pennsylvania School of Medicine.

Professor Ma pointed out the rapid rise of online medical diagnosis services during the pandemic and in the post-pandemic era. Online consultations have increased by 38 times in the past 18 months, while routine imaging examinations such as breast cancer screening have decreased by 80%. How to provide imaging service in the community (Imaging in Community) has become a challenge for the imaging industry. He introduced the initiative of Time Medical and Harvard School of Public Health to provide imaging screening services for lung infection and breast cancer in the community. It has triggered heated discussions among the participants, the CIBR has decided to set up a working group to guild community diagnosis-related regulations and data standardization.

Yuri (Left), Renee, Executive Director of the Coalition for Imaging & Bioengineering Research (CIBR) (Middle) and Professor Ma (Right)

Group Photo of Time Medical team at RSNA

Time Medical Biomed Established Ultra-high-field MRI Bio-imaging Experiment Center with Sichuan University West China Second University Hospital

Prof. Mu, Vice Chairman of West China Second University Hospital and Prof. Gao from Time Medical Discussed Cooperation on Experiment Center

Sichuan, China, May 27 – Shanghai Time Medical Biomed Limited (Time Medical Biomed) signed strategic cooperation agreement with Sichuan University West China Second University Hospital on 27th May at Sichuan University West China campus. Leveraging the strengths of both parties, the two confirmed cooperation on areas such as ultra-high-field MRI imaging products and experimental animal MRI imaging technologies etc. to achieve mutual beneficial development. The two co-found the “Sichuan University West China Second University Hospital – Time Medical Biomed Ultra-high-field MRI Bio-imaging Experiment Center” to further facilitate development and application of experimental animal advanced imaging technologies, and to establish high-standard and multi-functional experimental animal imaging platform. Prof. Dezhi Mu, Executive Vice Chairman of Sichuan University West China Second University Hospital, Ling Lin, Head of Technology Department of Sichuan University West China Second University Hospital, Prof. Yingkun Guo, Deputy Director of Radiology Department of Sichuan University West China Second University Hospital,  national distinguished expert Dr. Eric Gao, Time Medical Chief Technology Officer and Dr. Lyon Zhang, Time Medical Biomed General Manager etc. attended the signing ceremony.

Cooperation Agreement Signing Ceremony

Time Medical has recently setup a 7T ultra-high-field small animal MRI system in Sichuan University West China Experimental Animal Center and has passed installation inspection. This is the first installation of Time Medical Biomed’s ultra-high-field biomedical MRI system in prestige hospitals in China. Until now, Time Medical Biomed has installed 7T-9T ultra-high-field MRI systems in distinguished universities in China, which is a forerunner in the high-end medical equipment in the country. The system was installed in West China Second University Hospital during the epidemic in 2020 with all performance parameters met, receiving the acknowledgement from the client. Time Medical Biomed has now become the world’s second supplier of ultra-high-field biomedical MRI systems.

Time Medical Biomed 7T Ultra-High-Field Small Animal MRI System

Led by Prof. Yingkun Guo, Sichuan University West China Second University Hospital research team has conducted small animal research projects in different aspects and results will be published soon. Prof. Guo said, “Time Medical Biomed’s ultra-high-field MRI system is utilized for whole body imaging research of small animals (such as rats and mice), which includes investigations on their functions and metabolisms under various imaging techniques and models. The system can be used in imaging research and evaluation of nervous system, tumour, cardiovascular system and diseases in other systems and organs in the body, as well as fundamental research related to multimodal imaging such as molecular imaging and cell tracking.” The Center will also provide open animal imaging experiment platform service for clinical hospitals in West China and Sichuan in the future.

Examples of High-quality Small Animal Imaging Application

PICA installation at Bloemfontein in South Africa on 29 April, 2021

PICA has been recently installed in EmoyaMed at Bloemfontein, South Africa on 29 April 2021.

For more enquiry in South Africa market, please contact anoop@time-medical.com or +91-9818011587

Pisano and Gollán inaugurated the new resonator of the Municipal Hospital

With the presence of the Minister of Health of the province of Buenos Aires, Dr. Daniel Gollán, the Chief of Cabinet Dr. Salvador Giorgi, and the national deputy Eduardo Bali Bucca, Mayor Marcos Pisano inaugurated, this Wednesday, the renewed Service of Diagnostic Imaging of the Municipal Hospital, which now has its own magnetic resonator at the service of the community.

The meeting was accompanied by the provincial deputy Cesar Valicenti, the director of Sanitary Region IX, Lic. Ramiro Borzi, and the associate director of the Region, Norma Álvarez Morello.

During the visit to the city, the officials toured the Molecular Biology Laboratory, where they were received by the molecular biologist Rocío Larreche, who explained the daily work carried out in the place, where more than 10,000 samples have been taken from Bolivarians up to the moment and the demand of more than 10 neighboring towns is met.

Likewise, Gollán greeted the workers of the epidemiological footprint whom he congratulated for the work carried out, taking into account that days ago the media questioned the vaccination of volunteers who serve in the so-called early care CeTep for consultations of Covid-19: “In the face of attacks, work and commitment are the best response. We have to continue vaccinating, detecting and isolating, they are doing a great job and people recognize it, congratulations.

Next, they toured the Vaccination Center, in which more than 2,000 residents have been vaccinated so far. In the place Gollán learned about the mobile vaccination, which the mayor Pisano assigned to carry out home vaccination and in the Party's localities, an investment that the minister considered essential to guarantee access to the vaccine to the entire community.

"In April and May, vaccination will be accelerated with the arrival of doses to the country, to allow that when the cold season comes, the population at risk is more protected," said Gollán.

Later, they arrived at the M. Capredoni Hospital where they proceeded to the inauguration of the new hospital wing.

It is a fundamental work for the strengthening of public health, the equipment acquired with the help of the Buenos Aires government, through a loan from Banco Provincia at a fixed rate and with very favorable conditions, meant an investment of more than 60 million euros. pesos for municipal coffers.

The inauguration in the midst of the adverse context that the Covid-19 pandemic is going through, responds to the work articulated between the municipality of Bolívar and the Provincial Government. Regarding the purchase of the equipment, the mayor Pisano referred to the obstacles generated at first by the opposition and called on them to work together for the community: "Let's leave behind political selfishness, this is an achievement of all Bolivarians and not of the politician on duty, "said Pisano and added:" There were many obstacles, but none of them have stopped us; because when working for and for our communities, political flags cannot be a limit to the general benefit, even more so when what we are debating is Bolívar's public health, "said Pisano.

The latest generation device will allow a much faster and more accurate diagnosis and treatment to be reached, without the need to refer patients to neighboring towns. It should be noted that the statistics of the Municipal Hospital record that more than a thousand Bolivians in recent years carried out this study outside the city, this situation represented a complexity for the residents and also an important expense for the municipal administration.

“It is a joy to see the laboratory, the Vaccination Center with an impeccable organization and the resonator. It has been a very hard year and when I see the level of commitment that I saw here today, I think that nothing is impossible, "Gollán said and added:" We have to transform the province and here I see a management that puts everything to make it happen. I am very happy, I congratulate the mayor, we are going to continue working jointly so that this sad reality is transformed into opportunities that improve the quality of life of all Buenos Aires residents ”.

The renewed Diagnostic Imaging Service has an Ultrasound room, a Mammography room, an administrative office, and the Resonance and Command room, equipped with a futuristic design, and specifically adapted according to the requirements stipulated by the equipment supplier. last generation.

Within the framework of the inauguration, deputy Eduardo Bali Bucca said: "Our hospital grows and begins to provide new services incorporating technology and in solidarity, providing service to all Buenos Aires residents, something that Marcos dreamed of."

"This is a historic day, we paid off one more debt in the midst of the pandemic. Carrying out an unprecedented Vaccination Plan, and working daily with our municipal laboratory, we have the enormous satisfaction of continuing to strengthen our health system," said Pisano.

Faced with the adverse context, from the municipal administration Marcos Pisano continues to work on strengthening the health of the Bolívar Party, and betting on regional projection, since like the Molecular Biology Laboratory, a fundamental tool to face the pandemic, the resonator will provide the service to neighboring municipalities that do not have this opportunity for diagnosis and treatment, and appreciated for the contribution of our Distributor in Argentina GEMED S. R. L for this project.

Images credit by BOLIVAR - Pisano y Gollán inauguraron el nuevo resonador del Hospital Municipal

New PICA in Cambodia!

Time Medical has finished the installation of the PICA MRI System at Phnom Penh, Cambodia. We strive to serve more patients in different countries!

Break Through: Time Medical Systems Awarded Core Innovation Patents on MRI Ultra-High-Field Superconducting Magnet

China, June 15, 2018 – Time Medical Systems has recently been awarded two core innovation patents: an ultra-high-field superconducting magnet used in whole body MRI imaging, and an ultra-high-field superconducting magnet with high homogeneity used for MRI imaging of small animals. The patents awarded include multiple core techniques on the design and manufacture of 4.7T-or-above ultra-high-field superconducting magnet.

The manufacturing of ultra-high-field superconducting magnet involves techniques from a number of scientific areas including vacuum, thermology, mechanics, electromagnetism, mechanical engineering, large equipment manufacturing and fine machining. The level of difficulty is second only to manufacturing of engines of large aircrafts. At present, only two international corporations can manage all techniques on ultra-high-field superconducting magnets for MRI imaging. The details of design method and manufacturing process have always been highly confidential.

Time Medical continues to devote itself to the development of superconducting magnet for many years. During the “12th Five-Year Plan” period, Time Medical involved in the national superconducting magnet major project; in 2016, Time Medical designed and successfully manufactured the first 7T superconducting magnet product in Asia; in 2017, the company further overcame difficulties in 9T cryogen-free superconducting magnet. All key components of the 7T superconducting magnet and the 9T cryogen-free superconducting magnet are developed by Time Medical and are designed independently and manufactured in China. The performances of the magnets match with international leading standards, and in some aspects even exceed those developed by international competitors. In 2018 Time Medical’s 7T veterinary MRI system has already entered the biological and medical development market, with orders received from first-class universities and hospitals.

The award of patents not only demonstrates that Time Medical has mastered the core techniques in manufacturing of superconducting magnets, it also implies the company has completely possessed independent intellectual property rights, and has broken the monopoly of core technology on ultra-high-field superconducting magnet by international corporations. With the “Chinese Core” in ultra-high-field superconducting MRI sector, China is capable of competing in global market.